Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses Mark M. WhitmoreSong LiLeaf Huang Original Article Pages: 503 - 514
Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia Akira ItoMasashige ShinkaiTakeshi Kobayashi Original article Pages: 515 - 522
Immunoglobulin genes expressed by B-lymphocytes infiltrating cervical carcinomas show evidence of antigen-driven selection Philippa M. O'BrienEmmanouella TsirimonakiSaveria M. Campo Original Article Pages: 523 - 532
Improved survival in tumor-bearing SCID mice treated with interferon-γ-inducible protein 10 (IP-10/CXCL10) Douglas A. ArenbergEric S. WhiteRobert M. Strieter Original Article Pages: 533 - 538
Mutated SEA-D227A-conjugated antibodies greatly enhance antitumor activity against MUC1-expressing bile duct carcinoma Hideaki KodamaMasanori SuzukiToshio Kudo Original Article Pages: 539 - 548
Tumor-specific targeting of a cell line with natural killer cell activity by asialoglycoprotein receptor gene transfer Thomas SchirrmannGabriele Pecher Original Article Pages: 549 - 556
Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapy Laura SanzPeter KristensenLuis Álvarez-Vallina Original Article Pages: 557 - 565
T-helper (Th)1/Th2 imbalance in patients with previously untreated B-cell diffuse large cell lymphoma Takehiko MoriRie TakadaYasuo Ikeda Short Communication Pages: 566 - 568